{
    "Trade/Device Name(s)": [
        "HemoCue Hb 801 System"
    ],
    "Submitter Information": "HemoCue AB",
    "510(k) Number": "K181751",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061047"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKR"
    ],
    "Summary Letter Date": "June 27, 2018",
    "Summary Letter Received Date": "July 2, 2018",
    "Submission Date": "June 27, 2018",
    "Regulation Number(s)": [
        "21CFR864.5620"
    ],
    "Regulation Name(s)": [
        "Automated hemoglobin system"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Lithium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "HemoCue Hb 801 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric",
        "Photometric determination"
    ],
    "Methodologies": [
        "Spectrophotometry"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Consumable",
        "Microcuvette"
    ],
    "Document Summary": "FDA 510(k) summary for HemoCue Hb 801 System, a point-of-care spectrophotometric analyzer for quantitative hemoglobin measurement in whole blood",
    "Indications for Use Summary": "Intended for quantitative determination of hemoglobin in capillary or venous whole blood (K2EDTA and Li-Heparin) in point-of-care settings for adults, adolescents, children, and infants above 1 month old; for professional in vitro diagnostic use only",
    "fda_folder": "Hematology"
}